Mitro-aortic fibrosa pseudoaneurysm and concomitant aortic stenosis: How to kill two birds with a stone

Alberto Boi1, Giovanni Garau1, Angelica Rossi1

  • 1Interventional Cardiology, Azienda Ospedaliera Brotzu, Cagliari, Sardinia, Italy.

Insights

Pseudoaneurysm of the mitral-aortic intervalvular fibrosa (P-MAIVF) is a rare condition. Transapical transcatheter aortic valve implantation successfully excluded a P-MAIVF in a patient with severe aortic stenosis.

Area of Science:

  • Cardiology
  • Cardiac Surgery
  • Interventional Cardiology

Background:

  • Pseudoaneurysm of the mitral-aortic intervalvular fibrosa (P-MAIVF) is a rare acquired malformation.
  • It presents as a pulsatile cavity at the mitral-aortic junction, potentially leading to life-threatening complications.
  • P-MAIVF is often a complication of cardiac surgery, endocarditis, or trauma.

Observation:

  • This case report details a patient with severe aortic stenosis and a concomitant P-MAIVF.
  • The patient was considered high-risk for conventional surgery.

Findings:

  • Successful exclusion of the P-MAIVF was achieved using a transapical transcatheter aortic valve implantation (TA-TAVI) approach.
  • This minimally invasive technique provided an effective solution for a complex P-MAIVF in a high-risk patient.

Implications:

  • Transcatheter aortic valve implantation may represent a viable alternative treatment for P-MAIVF, particularly in patients unsuitable for open-heart surgery.
  • This approach offers a less invasive option for managing this rare but dangerous cardiac condition.
  • Further research into transcatheter techniques for P-MAIVF is warranted to establish its role in clinical practice.

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
159
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
157
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
241
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
179
Mitral Stenosis IV: Nursing Management01:27

Mitral Stenosis IV: Nursing Management

A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
191
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
234